Skip to content Accessibility statement

Search results

1 - 10 of 16 search results for methods estimation NICE cost effectiveness threshold. Try your search in the York Research Database

Publications archive - Centre for Health Economics

We retain an archive of in house publications by the Centre of Health Economics dating from 1984.

york.ac.uk/che/outputs/publications-archive

Karl Claxton - Centre for Health Economics

CHE research staff, Karl Claxton, Professor of Economics

york.ac.uk/che/people/karl-claxton

CHE research papers - Centre for Health Economics

Since our establishment in 1983, CHE has committed to sharing current and ongoing research projects with a global audience of health economists, policy makers and researchers.

york.ac.uk/che/outputs/research-papers

Journal articles - Centre for Health Economics

Researchers at CHE regularly publish their work in journals, books and other publications. 

york.ac.uk/che/outputs/journal-articles

Methods - Centre for Health Economics

CHE is a leader in health economics research with a strong application and development of methods.

york.ac.uk/che/methods

Research - EQUIPOL

Our research is interdisciplinary and aims to be both methodologically innovative and useful to policymakers seeking to make fairer decisions with better health outcomes.

york.ac.uk/healthsciences/research/health-policy/equipol/research

Increasing value for money in healthcare - Research

Research at York has had a direct impact on how health technologies, such as cancer drugs, are evaluated and made available in the UK and internationally.

york.ac.uk/research/impact/healthcare-value

2012 - Centre for Reviews and Dissemination

Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure. ... The clinical effectiveness and cost-effectiveness of low-intensity psychological…

york.ac.uk/crd/publications/journal-articles/2012

2022 - Centre for Reviews and Dissemination

The cost-effectiveness of selective internal radiation therapies compared with sorafenib for treating advanced unresectable hepatocellular carcinoma in the United Kingdom. ... Intensive…

york.ac.uk/crd/publications/journal-articles/2022